Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Standard of Care × 1 year × Clear all

Sponsor

Conditions

Neoplasms 30 Breast Neoplasms 29 Prostatic Neoplasms 22 Lung Neoplasms 22 Colorectal Neoplasms 19 Hematologic Neoplasms 13 Carcinoma, Non-Small-Cell Lung 13 Neoplasm Metastasis 11 Multiple Myeloma 10 Pancreatic Neoplasms 8 Hematopoietic and Lymphatic System Neoplasm 8 Squamous Cell Carcinoma of Head and Neck 7 Urinary Bladder Neoplasms 6 Stomach Neoplasms 6 Carcinoma, Renal Cell 6 Triple Negative Breast Neoplasms 5 Sarcoma 5 Ovarian Neoplasms 5 Motor Activity 5 Head and Neck Neoplasms 5 Anatomic Stage I Breast Cancer AJCC v8 5 Mouth Neoplasms 4 Melanoma 4 Leukemia, Myeloid, Acute 4 Gastrointestinal Neoplasms 4 Breast Carcinoma In Situ 4 Anxiety Disorders 4 Smoking 3 Recurrence 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Cyclophosphamide 28 fludarabine 20 Whole-Body Irradiation 19 fludarabine phosphate 18 asciminib 18 Mycophenolic Acid 17 nilotinib 14 Tacrolimus 14 Imatinib Mesylate 12 Melphalan 11 Dasatinib 9 ponatinib 8 bosutinib 8 Thiotepa 8 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 Mesna 6 Granulocyte Colony-Stimulating Factor 6 Filgrastim 5 venetoclax 4 olverembatinib 4 blinatumomab 4 Stem Cell Transplantation 4 Sirolimus 4 ruxolitinib 3 Rituximab 3 Hematopoietic Stem Cell Transplantation 3 Cyclosporine 3 Bone Marrow Transplantation 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡